| |
|
|
|
Aldeyra Therapeu
|
|
3.90 -0.35 (-8.24%) |
8/21/2017 3:59pm |
|
Open: |
4.25 |
Pre close: |
4.25 |
Target:
|
5.42 
|
|
High: |
4.25 |
Low: |
3.90 |
Resistance:
|
4.64
5.10
|
|
Volume: |
34,751 |
Market Cap: |
24.36M |
Support:
|
3.90
3.24
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.17
|
MACD |
MACD(12,26):
|
-0.16 |
|
MA(20): |
4.48 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
4.62 |
Stochastic Oscillator |
%K(14,3):
|
19.30 |
|
MA(250): |
5.25 |
%D(3): |
21.98  |
|
Average Volume(K) |
3-Month: |
6122
|
52-Week |
High:
|
8.19 |
|
10-Days: |
1493 |
Low: |
3.80 |
|
RSI |
RSI(14):
|
32.77 |
Change(%): |
-30.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.520 |
Return on Equity (ttm) |
-75.0 |
Shares Out. (M) |
15.13 |
|
EPS Est. Current Year |
-1.630 |
Return on Assets (ttm) |
-41.8 |
Shares Float (M) |
2.02 |
|
EPS Est. Next Year |
-1.770 |
PEG Ratio |
0.00 |
% Held by Insiders |
38.54 |
|
EPS Est. Next Quarter |
-0.410 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
43.50 |
|
Forward EPS |
-1.841 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
115 |
|
Book Value (p.s.) |
1.850 |
EBITDA (p.s.) |
-1.310 |
P/E |
-2.57 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.11 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.91 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-10.01 |
P/CF |
-3.49 |
|
|
|
|
|
|
|
